600486.SS SHH
Jiangsu Yangnong Chemical Co., Ltd.
1W: -2.9%
1M: -8.0%
3M: -0.4%
YTD: -31.2%
1Y: -20.6%
3Y: -23.4%
5Y: -37.4%
¥51.18 ($7.63)
+0.73 (+1.45%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$17.7B
+12.5% ▲
5Y CAGR: +12.9%
Total Liabilities
$7.1B
+18.2% ▲
5Y CAGR: +9.2%
Shareholders Equity
$10.5B
+8.9% ▲
5Y CAGR: +15.8%
Cash & Investments
$1.6B
-56.4% ▼
5Y CAGR: -7.0%
Total Debt
$1.2B
+227.9% ▲
5Y CAGR: -2.3%
Net Debt
-$425M
-156.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.9B | $2.3B | $3.4B | $1.8B | $1.6B |
| Short-Term Investments | $0 | $0 | $0 | $2.0B | $0 |
| Cash & ST Investments | $1.9B | $2.3B | $3.4B | $3.7B | $1.6B |
| Net Receivables | $1.9B | $2.9B | $3.4B | $3.3B | $3.6B |
| Inventory | $1.6B | $1.9B | $2.1B | $1.6B | $1.1B |
| Other Current Assets | $972M | $843M | $525M | $5M | $705M |
| Total Current Assets | $6.4B | $7.9B | $9.3B | $9.1B | $7.2B |
| Property, Plant & Equip. | $3.8B | $4.6B | $4.5B | $5.4B | $7.2B |
| Goodwill & Intangibles | $522M | $507M | $631M | $657M | $600M |
| Long-Term Investments | $51M | $7M | $2M | $103M | $0 |
| Other Non-Current Assets | $51M | $47M | $97M | $214M | $2.4B |
| Total Non-Current Assets | $4.5B | $5.3B | $5.5B | $6.6B | $10.5B |
| Total Assets | $10.9B | $13.1B | $14.8B | $15.7B | $17.7B |
| — Liabilities — | |||||
| Accounts Payable | $2.7B | $2.5B | $2.3B | $3.7B | $4.5B |
| Short-Term Debt | $451M | $834M | $558M | $611M | $1.2B |
| Deferred Revenue | $882M | $1.5B | $696M | $0 | $0 |
| Other Current Liabilities | $74M | $593M | $1.3B | $1.4B | $151M |
| Total Current Liabilities | $4.1B | $5.7B | $5.8B | $5.7B | $6.6B |
| Long-Term Debt | $553M | $253M | $253M | $3M | $0 |
| Other Non-Current Liab. | $180M | $5M | $185M | $186M | $384M |
| Total Non-Current Liabilities | $841M | $432M | $493M | $281M | $493M |
| Total Liabilities | $4.9B | $6.2B | $6.3B | $6.0B | $7.1B |
| — Equity — | |||||
| Common Stock | $310M | $310M | $310M | $406M | $407M |
| Retained Earnings | $4.6B | $5.6B | $7.2B | $8.2B | $9.0B |
| Accumulated OCI | $432M | $446M | $471M | $63M | $62M |
| Total Stockholders Equity | $5.9B | $6.9B | $8.5B | $9.7B | $10.5B |
| Total Liabilities & Equity | $10.9B | $13.1B | $14.8B | $15.7B | $17.7B |
| — Key Metrics — | |||||
| Total Debt | $1.0B | $1.1B | $818M | $364M | $1.2B |
| Net Debt | -$887M | -$1.2B | -$2.5B | $758M | -$425M |
| Total Investments | $51M | $7M | $2M | $2.1B | $0 |